Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CAS gets US grant for adult brain oxygen monitor:

This article was originally published in Clinica

Executive Summary

CAS Medical Systems has gained a $1m US grant to continue its development of a noninvasive device for measuring brain oxygenation in adults. The National Institutes of Health award will be used to refine the product, which is based on near-infrared spectroscopy (NIRS). It will also be used to test and construct pre-manufacturing prototypes. The system will include a monitoring device incorporating proprietary algorithms and a patient sensor that is placed on the forehead. It will enable a rapid indication of absolute brain blood oxygenation saturation and, indirectly, brain circulatory haemodynamic changes, providing healthcare workers with information to guard against neurological injuries due to compromised brain oxygenation, which can often occur during many surgical and clinical situations. The Branford, Connecticut firm also has a phase II grant to apply the technology to neonates.

You may also be interested in...

The Race Is On To Launch COVID-19 Antibody Home-Test In The UK

Feature: Public Health England has revealed it is only a week away from approving a COVID-19 antibody test for distribution via Amazon. HBW Insight looks at the race to place the first, government-approved coronavirus home-test on the UK market.

COVID-19: Medtronic Shares Ventilator Specs Amid Multi-Industry Efforts To Increase Ventilator Production

Medtronic shares an open-source design for its ventilator to help mitigate the nation’s ventilator shortage for COVID-19 patients.

Russia May Cap Drug Prices In Fight Against COVID-19

As part of its efforts to preserve patient access to medicines amid the COVID-19 pandemic, Russia is planning to cap drug prices if increases of more than 30% are detected. It will also allow online sales of non-prescription drugs and may also tighten the rules on fake and substandard products. 





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts